Critical Outcome T Stock Price, News & Analysis (OTCMKTS:COTQF)

$0.79 0.03 (3.94 %)
(As of 12/15/2017 04:00 PM ET)
Previous Close$0.79
Today's Range$0.79 - $0.80
52-Week Range$0.76 - $4.80
Volume3,700 shs
Average Volume1,617 shs
Market Capitalization$13.19 million
P/E RatioN/A
Dividend YieldN/A
Beta2.06

About Critical Outcome T (OTCMKTS:COTQF)

Critical Outcome T logoCritical Outcome Technologies Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of cancer in Canada. The company’s proprietary artificial intelligence platform, CHEMSAS, utilizes a series of predictive computer models to identify compounds from disease specific drug discovery through chemical optimization and preclinical testing. Its lead compound is COTI-2, a novel small molecule activator of misfolded mutant p53 proteins, which is in Phase I clinical trial for the treatment of gynecologic cancers, including ovarian, cervical, and endometrial cancers. The company also develops drug candidates for the treatment of acute myelogenous leukemia, colorectal cancer, small cell lung cancer, multiple sclerosis, and Alzheimer’s disease; and HIV integrase inhibitors. Critical Outcome Technologies Inc. was founded in 1999 and is based in London, Canada.

Receive COTQF News and Ratings via Email

Sign-up to receive the latest news and ratings for COTQF and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorMedical
SymbolOTCMKTS:COTQF
CUSIPN/A
Phone519-858-5157

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book Value$0.21 per share
Price / Book3.76

Profitability

Trailing EPS($0.40)
Net Income$-4,670,000.00
Net MarginsN/A
Return on Equity-216.27%
Return on Assets-94.74%

Miscellaneous

Employees7
Outstanding Shares16,690,000

Critical Outcome T (OTCMKTS:COTQF) Frequently Asked Questions

What is Critical Outcome T's stock symbol?

Critical Outcome T trades on the OTCMKTS under the ticker symbol "COTQF."

How were Critical Outcome T's earnings last quarter?

Critical Outcome T (OTCMKTS:COTQF) posted its quarterly earnings results on Wednesday, December, 18th. The company reported ($0.01) EPS for the quarter. View Critical Outcome T's Earnings History.

Who are some of Critical Outcome T's key competitors?

How do I buy Critical Outcome T stock?

Shares of Critical Outcome T can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Critical Outcome T's stock price today?

One share of Critical Outcome T stock can currently be purchased for approximately $0.79.

How big of a company is Critical Outcome T?

Critical Outcome T has a market capitalization of $13.19 million. The company earns $-4,670,000.00 in net income (profit) each year or ($0.40) on an earnings per share basis. Critical Outcome T employs 7 workers across the globe.

How can I contact Critical Outcome T?

Critical Outcome T's mailing address is 700 Collip Circle Suite 213, London A6, N6G 4X8. The company can be reached via phone at 519-858-5157 or via email at [email protected]


MarketBeat Community Rating for Critical Outcome T (COTQF)

Community Ranking:  1.7 out of 5 (star)
Outperform Votes:  36 (Vote Outperform)
Underperform Votes:  69 (Vote Underperform)
Total Votes:  105
MarketBeat's community ratings are surveys of what our community members think about Critical Outcome T and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Critical Outcome T (OTCMKTS:COTQF) Analyst Ratings History


No equities research coverage for this company has been tracked by MarketBeat

Earnings

Critical Outcome T (OTCMKTS:COTQF) Earnings History and Estimates Chart

Earnings by Quarter for Critical Outcome T (OTCMKTS:COTQF)

Critical Outcome T (OTCMKTS COTQF) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
12/18/2013Q3($0.01)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Critical Outcome T (OTCMKTS:COTQF) Earnings Estimates

Current Year EPS Consensus Estimate: $-0.3 EPS
Next Year EPS Consensus Estimate: $-0.42 EPS

Dividends

Dividend History for Critical Outcome T (OTCMKTS:COTQF)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Critical Outcome T (OTCMKTS COTQF)

No insider trades for this company have been tracked by MarketBeat.com

Headlines

Critical Outcome T (OTCMKTS COTQF) News Headlines

Source:
DateHeadline
Critical Outcome Technologies Annual and Special Meeting of Shareholders RescheduledCritical Outcome Technologies Annual and Special Meeting of Shareholders Rescheduled
finance.yahoo.com - December 7 at 9:12 AM
Critical Outcome T (COTQF) Upgraded by Zacks Investment Research to "Hold"Critical Outcome T (COTQF) Upgraded by Zacks Investment Research to "Hold"
www.americanbankingnews.com - December 6 at 5:40 PM
BRIEF-Critical Outcome gets pharmacokinetic data from phase 1 COTI-2 trialBRIEF-Critical Outcome gets pharmacokinetic data from phase 1 COTI-2 trial
www.reuters.com - November 16 at 6:04 PM
Critical Outcome Technologies Announces Pharmacokinetic Data From Phase 1 Dose Escalation Portion of COTI-2 Trial in Gynecological MalignanciesCritical Outcome Technologies Announces Pharmacokinetic Data From Phase 1 Dose Escalation Portion of COTI-2 Trial in Gynecological Malignancies
finance.yahoo.com - November 16 at 1:00 PM
What Does Critical Outcome Technologies Inc’s (TSXV:COT) Ownership Structure Look Like?What Does Critical Outcome Technologies Inc’s (TSXV:COT) Ownership Structure Look Like?
finance.yahoo.com - November 16 at 1:00 PM
Finally, well hear from Comey about RussiaFinally, we'll hear from Comey about Russia
www.cnn.com - March 18 at 4:16 PM
Why The AMA And Mayo Clinic Caution Against GOP Insurance CutsWhy The AMA And Mayo Clinic Caution Against GOP Insurance Cuts
www.forbes.com - March 13 at 4:31 PM
What Happens When You Fight a ‘Deep State’ That Doesn’t ExistWhat Happens When You Fight a ‘Deep State’ That Doesn’t Exist
www.nytimes.com - March 11 at 9:25 PM
The AI Debate Critical To The Future Of Autonomous VehiclesThe AI Debate Critical To The Future Of Autonomous Vehicles
www.forbes.com - March 9 at 5:02 PM
Geron: Speculative Biotech With Upcoming CatalystGeron: Speculative Biotech With Upcoming Catalyst
seekingalpha.com - March 9 at 3:20 AM
Trump’s Address to Congress Satisfies Immigration Hardliners on the HillTrump’s Address to Congress Satisfies Immigration Hardliners on the Hill
www.nbcnews.com - March 1 at 9:29 PM
Few people know about overlapping surgeryFew people know about overlapping surgery
www.foxnews.com - March 1 at 9:46 AM
Oscars 2017 updates: Jimmy Kimmel explains what happened on stage and the Academy officially apologizesOscars 2017 updates: Jimmy Kimmel explains what happened on stage and the Academy officially apologizes
www.latimes.com - February 28 at 4:22 PM
Scientists highlight deadly health risks of climate changeScientists highlight deadly health risks of climate change
www.cnn.com - February 16 at 9:33 PM
BRIEF-Critical outcome technologies announces departure of chief scientific officerBRIEF-Critical outcome technologies announces departure of chief scientific officer
www.reuters.com - February 1 at 4:47 PM
Critical Outcome Technologies (COTQF) Presents At Cantech Investment ConferenceCritical Outcome Technologies (COTQF) Presents At Cantech Investment Conference
seekingalpha.com - January 21 at 3:41 AM

SEC Filings

Critical Outcome T (OTCMKTS:COTQF) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Financials are not available for this stock.

Chart

Critical Outcome T (OTCMKTS COTQF) Stock Chart for Saturday, December, 16, 2017

Loading chart…

This page was last updated on 12/16/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.